GSA Capital Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,559
| Closed | -$1.27M | – | 1895 |
|
|
2021
Q3 | $1.27M | Buy |
17,559
+251
| +1% | +$18.1K | 0.13% | 195 |
|
|
2021
Q2 | $1.66M | Buy |
17,308
+14,250
| +466% | +$1.37M | 0.19% | 96 |
|
|
2021
Q1 | $452K | Sell |
3,058
-3,011
| -50% | -$445K | 0.08% | 409 |
|
|
2020
Q4 | $849K | Buy |
6,069
+1,240
| +26% | +$173K | 0.14% | 179 |
|
|
2020
Q3 | $733K | Buy |
+4,829
| New | +$733K | 0.12% | 210 |
|
|
2016
Q3 | – | Sell |
-132
| Closed | -$144K | – | 2019 |
|
|
2016
Q2 | $144K | Buy |
+132
| New | +$144K | 0.01% | 1636 |
|